Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 25, 2025 19:51 ET | Source: ASUS Computer International

Republic of Gamers Announces Next-Gen RTX 50 Series Laptop Lineup – Now Available for Pre-Order in Canada

Republic of Gamers Announces Next-Gen RTX 50 Series Laptops – Now Available for Pre-Order in Canada, Including Strix Scar, Strix G, and Zephyrus Models
January 06, 2025 23:35 ET | Source: ASUS Computer International

ASUS ROG Unveils Latest Innovations Forged to Unlock Limitless Gaming Potential at CES 2025

ROG redefines gaming with its powerful lineup of NVIDIA GeForce RTX 50 Series gaming laptops, desktops, and external GPUs.
November 25, 2024 09:45 ET | Source: ASUS Computer International

Unmissable Black Friday Deals on the ASUS Store in Canada

Unbeatable savings: Save up to $1,000 on the best ASUS Black Friday deals, with laptops ranging from gaming handhelds, consumer, gaming laptops, and more!
August 21, 2024 16:37 ET | Source: ASUS Computer International

ASUS Republic of Gamers Announces the ROG Zephyrus G16 (2024) GA605, Now Available in Canada

The new AMD Ryzen™ AI processor and NVIDIA® GeForce RTX™ 40 Series graphics brings new levels of AI-powered work and play to the Zephyrus laptop family
April 03, 2023 07:00 ET | Source: FibroGen, Inc.

FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-2, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis

- 372 IPF Patients Enrolled -- Topline Data Anticipated Mid-2024 - SAN FRANCISCO, April 03, 2023 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the completion of patient...
April 20, 2022 07:00 ET | Source: FibroGen, Inc.

FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-1, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis

- 356 IPF Patients Enrolled - - Topline Data Anticipated Mid-2023 - SAN FRANCISCO, April 20, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced completion of patient...
July 22, 2019 07:00 ET | Source: FibroGen, Inc

FibroGen Announces First Patient Dosed in ZEPHYRUS, a Phase 3 Clinical Trial of Pamrevlumab for the Treatment of Patients with Idiopathic Pulmonary Fibrosis

SAN FRANCISCO, July 22, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), today announced dosing of the first patient in the ZEPHYRUS Phase 3 clinical study of pamrevlumab in patients with...